The New Parkinsons Disease Treatment Book Partnering with Your Doctor to Get the Most from Your Medications
and family. Dr. Ahlskog's goal is to educate patients so that they can better team up with their doctors to do battle with the disease, streamlining the decision-making process and enhancing their treatment. To do this, Dr. Ahlskog offers a gold mine of information, distilled from his years of
experience treating people with Parkinson's at the Mayo Clinic. In addition to providing a comprehensive account of Parkinson's medications, this book also examines additional aspects of treatment, such as the role of nutrition, exercise, and physical therapy. Although many commendable texts have been written on the subject of Parkinson's Disease, their discussions of treatment have not been in depth. Dr. Ahlskog sifts through aspects of the disease in order to give the reader a comprehensive sense of Parkinson's and the best available treatment options.
With a broader understanding of the disease and the available options, patients are able to make more informed choices, and doctors are able to provide more tailored care. This book delivers hopeful, helpful, and extensive information to all parties concerned: patients, caregivers, and doctors. The ultimate guide to symptoms and treatment, this thoroughly updated second edition is the first place patients should turn for reliable, easy-to-grasp information on Parkinson's Disease.
| Publisher Name | Oxford University Press USA |
|---|---|
| Author Name | Hagendorf, Col |
| Format | Audio |
| Bisac Subject Major | HEA |
| Language | NG |
| Isbn 10 | 0190231866 |
| Isbn 13 | 9780190231866 |
| Target Age Group | min:NA, max:NA |
| Dimensions | 00.93" H x 00.06" L x 30.00" W |
| Page Count | 544 |
J. Eric Ahlskog, PhD, MD, is Professor of Neurology at the Mayo Medical School, and Chair of the Mayo Section of Movement Disorders, Mayo Clinic, Rochester, Minnesota. Widely considered to be a leading authority on this disorder, he has more than 30 years of experience treating people with
Parkinson's Disease, both in the clinic as a full-time, patient-seeing neurologist, and as a clinical-investigator responsible for PD treatment protocols.
